Heron Therapeutics Inc (STU:AXD2)
€ 1.728 0.056 (3.35%) Market Cap: 266.05 Mil Enterprise Value: 366.24 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 71/100

Heron Therapeutics Inc Annual Shareholders Meeting Transcript

Jun 17, 2020 / 04:00PM GMT
Release Date Price: €17.6 (+2.33%)
Barry D. Quart
Heron Therapeutics, Inc. - President, CEO & Director

Good morning, ladies and gentlemen, and welcome to Heron Therapeutics 2020 Annual Meeting of Stockholders. My name is Barry Quart, and I serve as President, Chief Executive Officer of Heron Therapeutics. I'll be presiding over this meeting. At this time, I call the meeting to order. I will act as Chairman of the meeting. The Board has appointed David Szekeres to serve as our inspector of elections.

We are pleased to hold this meeting virtually for the first time this year as we aim to increase access and participation and to do our part to limit travel and large physical gatherings in light of the ongoing pandemic resulting from COVID-19. Stockholders may submit questions related to matters being voted on during the meeting in the space provided on the virtual shareholder meeting screen. Questions should pertain to the proposals being considered at the particular time and should be submitted before the polls close. As noted in the notice and proxy statement previously provided to stockholders, the record date for voting at

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot